{"entity":{"type":"insider","cik":"0001366200","url":"/insider/0001366200","json_url":"/insider/0001366200.json","name":"Reilly Dennis","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2020-03-06","last":"2021-10-14","span_basis":"filed_date"},"name_variants":[{"name":"Reilly Dennis","source":"filing","n_filings":6,"first_seen":"2020-03-06","last_seen":"2021-10-14"}],"transactions":[{"id":4720927,"accession":"0001104659-21-126014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-126014","line_url":"/filing/0001104659-21-126014#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001366200","owner_name":"Reilly Dennis","owner_display_name":"Reilly Dennis","owner_url":"/insider/0001366200","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58824.0,"shares_display":"58,824","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":285130.0,"shares_owned_after_display":"285,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-13","filed_date":"2021-10-14","scope":"insider"},{"id":4458367,"accession":"0001104659-21-097152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-097152","line_url":"/filing/0001104659-21-097152#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001366200","owner_name":"Reilly Dennis","owner_display_name":"Reilly Dennis","owner_url":"/insider/0001366200","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.0829,"price_display":"1.08","price_state":"stated","total_value":54145.0,"total_display":"54,145.00","total_whole":"54,145","shares_owned_after":226306.0,"shares_owned_after_display":"226,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-27","filed_date":"2021-07-28","scope":"insider"},{"id":5096760,"accession":"0001104659-21-065161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-065161","line_url":"/filing/0001104659-21-065161#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001366200","owner_name":"Reilly Dennis","owner_display_name":"Reilly Dennis","owner_url":"/insider/0001366200","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":27000.0,"total_display":"27,000.00","total_whole":"27,000","shares_owned_after":176306.0,"shares_owned_after_display":"176,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-12","scope":"insider"},{"id":5206054,"accession":"0001104659-21-040395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-040395","line_url":"/filing/0001104659-21-040395#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001366200","owner_name":"Reilly Dennis","owner_display_name":"Reilly Dennis","owner_url":"/insider/0001366200","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":102500.0,"total_display":"102,500.00","total_whole":"102,500","shares_owned_after":156306.0,"shares_owned_after_display":"156,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-23","filed_date":"2021-03-23","scope":"insider"},{"id":2142630,"accession":"0001104659-20-109302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-109302","line_url":"/filing/0001104659-20-109302#line-1","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001366200","owner_name":"Reilly Dennis","owner_display_name":"Reilly Dennis","owner_url":"/insider/0001366200","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":25650.0,"total_display":"25,650.00","total_whole":"25,650","shares_owned_after":106306.0,"shares_owned_after_display":"106,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-28","filed_date":"2020-09-28","scope":"insider"},{"id":2957921,"accession":"0001104659-20-029907","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-029907","line_url":"/filing/0001104659-20-029907","is_derivative":false,"issuer_cik":"0001261249","issuer_name":"AGILE THERAPEUTICS INC","issuer_ticker":"AGRX","issuer_name_source":null,"issuer_url":"/issuer/0001261249","owner_cik":"0001366200","owner_name":"Reilly Dennis","owner_display_name":"Reilly Dennis","owner_url":"/insider/0001366200","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":2.33,"price_display":"2.33","price_state":"stated","total_value":174750.0,"total_display":"174,750.00","total_whole":"174,750","shares_owned_after":59806.0,"shares_owned_after_display":"59,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-04","filed_date":"2020-03-06","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001261249","name":"AGILE THERAPEUTICS INC","url":"/issuer/0001261249","role":"Officer (Chief Financial Officer)","n_filings":6,"first_seen":"2020-03-06","last_seen":"2021-10-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001366200","retrieved_at":"2026-08-25T14:19:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}